AbbVie is investing $380 million to build two new active pharmaceutical ingredient manufacturing facilities at its headquarters campus in North Chicago. Construction is set to begin in spring 2026, ...

Beyond dashboards building data enables Stanford Health Care to deliver actionable, explainable insights for precision medicine workflows.

Post-acute company buys two New York nursing homes for $82.4 million, expanding its portfolio to 39 facilities across six states.

Study raises MRI safety concerns for nerve implants by showing risks of unintended nerve stimulation during scans with cuff electrodes.

Bayer has filed a lawsuit against Johnson & Johnson and Janssen Biotech, alleging the companies made false and misleading claims about the efficacy of its prostate cancer drug Nubeqa compared to the ...

Vanderbilt University Medical Center in Nashville, Tenn., has identified more than 70 medical conditions that consistently preceded Alzheimer’s disease diagnoses using EHR data from two large patient ...

CVS raises bonuses corporate employees by 42% after exceeding 2025 operating income targets, reflecting strong financial performance and key ...

San Diego Health Innovation chief Alexander Khalessi details the enterprise approach to scaling AI across seven campuses and clinical operations.

The FDA OKs pill schizophrenia and bipolar disorder treatment with Bysanti, a new atypical antipsychotic approved for adults.

Quiet majority medicine raises key challenges as women become the majority in U.S. residency programs, highlighting gaps in pay and leadership roles.

Novo Nordisk will reduce the U.S. list price of Wegovy, Ozempic and Rybelsus to $675 per month starting Jan. 1, 2027. The change constitutes a list price reduction of approximately 50% for Wegovy and ...

Healthcare’s workforce crisis is no longer a temporary disruption. It is becoming a defining structural test for the industry’s next era. Margins remain thin and technology is advancing faster than ...